Related Experiment Video
Updated: Jul 9, 2026
05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Prediction of preeclampsia - a workshop report
N G Than1, R Romero, R Hillermann
1First Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary. nthan@med.wayne.ed
Placenta
|December 7, 2007
Summary
Early preeclampsia detection is challenging. Biomarkers like placental growth factor and activin A in maternal blood may aid risk assessment, but a combination of markers is likely needed for comprehensive prediction.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Biochemistry
Background:
- Preeclampsia pathogenesis and early risk assessment remain significant clinical challenges.
- Maternal serum protein concentrations, including placental growth factor (PlGF), soluble vascular endothelial growth factor receptor-1 (sFlt-1), and soluble endoglin (sEng), change weeks before preeclampsia onset.
- Emerging biomarkers such as activin A, inhibin A, pregnancy-associated plasma protein-A (PAPP-A), and placental protein 13 (PP13) show promise for first-trimester risk stratification.
Framework:
- The complexity of preeclampsia suggests it is a syndrome with potentially diverse underlying mechanisms.
- A single diagnostic test is unlikely to accurately predict all presentations of preeclampsia.
- A novel conceptual framework proposes that a multimodal approach combining various markers is necessary for effective risk assessment.
Implementation:
- Monitoring specific circulating proteins in maternal blood offers potential for early detection.
- Investigating novel biomarkers in the first trimester could improve early risk identification.
- Developing combined biochemical and biophysical marker panels is crucial for comprehensive assessment.
Implications:
- Improved early risk assessment for preeclampsia can lead to timely interventions and better maternal-fetal outcomes.
- A comprehensive marker strategy may enhance the accuracy and scope of preeclampsia prediction.
- This approach could facilitate personalized risk stratification and management protocols for pregnant individuals.
Related Concept Videos
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:10Pre-Procedural Guidelines for Assessing Blood Pressure
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.